Atal Innovation Mission, NITI Aayog has partnered with Aster DM Health care to support proactively the mission’s innovation and entrepreneurship initiatives across the country with an aim to change and improve health care innovations and outcomes.
A Statement of Intent (SoI) of a strategic partnership between AIM and Aster was signed and exchanged between the two for the same. The purpose of SoI aims to support the various initiative of AIM programs and AIM beneficiaries in India to promote innovation and entrepreneurship amongst the aspiring entrepreneurs in the area of digital health care.
A unit of Aster DM Healthcare Group, Aster Digital Health Incubator (ADHI) will play a major role in supporting various Atal Incubation Centers (AICs), Established Incubation Centres (EICs),Atal Community Innovation Centres (ACICs) and Atal Tinkering Labs (ATLs) amongst other initiatives of AIM within the country.
The goal is to deeply engage with AICs, EIC, and ATLs across the country to achieve milestones in the area of health care innovative solutions with a focus on digital primary care and establishing a rich eco-system of digital health entrepreneurship.
In accordance with SoI with AIM, Aster will also be providing access to Aster Clinical Simulation Lab, Aster Federated Learning Data bank for AI healthcare research, ADHI, Aster Digital Health Center of Excellence, and other relevant facilities to the startups under various AIM initiatives.
Mission Director AIM, NITI Aayog R Ramanan while exchanging the virtual SoIwith Aster said that “the partnership will transform India’s health care ecosystem across the country.
“Collaborative value-adding partnerships with the private sector and international organizations is key to AIM’s initiatives to boost Innovation and Entrepreneurship nationwide. The partnership of AIM with Aster will greatly value add in the efforts to innovate in India’s medical devices and health care ecosystem leveraging advances in digital health research and innovation that Aster would enable,” he said.
Group Chief of Innovation & Research, Dr. Satish Prasad Rath said, “Digital health powered by deep learning/ AI has transformative ability to make healthcare accessible and affordable in India. Digital health startups often face the challenge of generating evidence of their utility as well focusing onthe need felt by doctors and patients. With Aster’s clinical simulation lab, a unique initiative from Aster’s Innovation and Research Centre, startups can validate their models with real world data available at Aster Data Bank. Taking advantage of the hospital immersion program startups can gain insights from nurses, doctors, health workers and CXOs which is going to be critical for their market adoption
Prime Minister Shri Narendra Modi will hold Virtual Summit with the Prime Minister of the Finland H.E. Ms Sanna Marin on 16 March 2021.
India and Finland enjoy warm and friendly relations based on shared values of democracy, freedom and rules based international order. Both countries have very close cooperation in the areas of trade and investment, education, innovation, Science & Technology as well as Research and Development. Both sides also have ongoing collaboration in the joint development of a Quantum Computer using Artificial Intelligence to address societal challenges. Around 100 Finnish companies are actively operating in India in various sectors such as telecom, elevators, machinery and energy including Renewable Energy. Around 30 Indian companies are also active in Finland mainly in IT, auto-components and hospitality sector.
During the Summit, the two leaders will cover the entire spectrum of bilateral relationship and will also exchange views on regional and global issues of mutual interest. The Virtual Summit will provide a blueprint for the future expansion and diversification of India-Finland Partnership.
Currently in India, laptops of worth Rs 30,000 crore and tablets worth Rs 3,000 crore are sold in India. Out of them, 80 per cent of are imported. Thus, this new PLI scheme was launched with which, government hopes to pull the top 5 global companies to India which controls 50 per cent of the international market.
Government has also extended the PLI scheme of worth Rs 15,000 crore for pharmaceuticals. This move was taken in order to reduce the imports and boost the domestic production. Currently, the Indian pharmaceutical industry is $40 billion and it contributes around 3.5 per cent to the global market. But the high-end patented drugs are still imported. The extension of PLI Scheme to pharmaceuticals will make it globally competitive.
This scheme is an outcome oriented as well as output-oriented scheme in which the incentives are paid only if the manufacturers make the goods. It provides cash incentives for five to seven years. Under this scheme all the important sectors are covered ranging from automobiles, food processing, advanced chemistry, Pharma, Solar PV manufacturing etc.
The International Commission on Large Dams (ICOLD) Symposium on Sustainable Development of Dams & River Basins was inaugurated by the Minister for Jal Shakti, Shri Gajendra Singh Shekhawat, on February 24, 2021.
Under the event, the achievement of the Dam Rehabilitation Improvement Project (DRIP), that was launched to improve the safety and operational performance of large dams and its appurtenances structures, will be presented to the Global Dam Community who are looking forward to India’s development. Further, the Dam Safety Bill which was approved by Lok Sabha, to put the regulatory mechanism and proper surveillance, operation, inspection and maintenance of all dams in India will also be publicised.
